Patrick Frost, PhD

Patrick Frost, PhD

Feb 02, 2016

Group 6 Copy 49
-2
Please wait...

About This Project

BBRI and Los Angeles VA Medical Center

Multiple myeloma (MM) is a cancer of the bone marrow made up of plasma cells (a type of antibody-producing white blood cells). Low oxygen levels (called hypoxia) in the bone marrow increases gene expression in MM tumor cells as part of an adaptive survival response. We are targeting this hypoxic response with an experimental drug that blocks expression of these genes to ask if this molecule kills MM in the bone marrow. This is a novel approach to treat MM, an incurable disease.

Blast off!

Browse Other Projects on Experiment

Related Projects

A fossil leaf site west of Ellensburg: part of the Ellensburg Flora? Or its own thing?

An ash-laden fossil leaf deposit in Central Washington assigned to the Ellensburg Flora (12 to 10 million...

Low cost snake antivenom for Asia, Africa and South America

Death by snake venom in India, Africa, and South America are substantial. Traditional antidotes are prohibitively...

Backer Badge Funded